Phase II study of first-line capecitabine and cetuximab for treatment of metastatic colorectal cancer in elderly patients and/or those with multiple comorbidities unable to receive chemotherapy doublets.
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2014
At a glance
- Drugs Capecitabine (Primary) ; Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 24 Jul 2006 New trial record.